Hepatitis C virus (HCV) downregulates the retinoblastoma tumor suppressor protein (Rb), a central cell cycle regulator which is also targeted by oncoproteins expressed by DNA tumor viruses. HCV genome replication is also enhanced in proliferating cells. Thus, it is possible that HCV interactions with host cell cycle regulators, such as Rb, have evolved to modify the intracellular environment to promote viral replication. To test this hypothesis and to determine the impact of viral regulation of Rb on HCV replication, we constructed infectious viral genomes containing mutations in the Rb-binding motif of NS5B which ablate the ability of HCV to regulate Rb. These genomes underwent replication in transfected cells but produced variably reduced virus yields. One mutant, L314A, was severely compromised for replication and rapidly mutated to L314V, thereby restoring both Rb regulation and replication competence. Another mutant, C316A, also failed to downregulate Rb abundance and produced virus yields that were about one-third that of virus with the wild-type (wt) NS5B sequence. Despite this loss of replication competence, purified NS5B-C316A protein was two-to threefold more active than wt NS5B in cell-free polymerase and replicase assays. Although small interfering RNA knockdown of Rb did not rescue the replication fitness of these mutants, we conclude that the defect in replication fitness is not due to defective polymerase or replicase function and is more likely to result from the inability of the mutated NS5B to optimally regulate Rb abundance and thereby modulate host gene expression.Chronic infection with hepatitis C virus (HCV) is associated with an increased risk for development of hepatocellular carcinoma (11). However, unlike most viruses associated with cancer, HCV has an RNA genome and an exclusively cytoplasmic life cycle. The precise mechanisms by which HCV infection leads to carcinogenesis are unclear. Although chronic inflammation is suspected to play a role, transgenic mice that express a low abundance of the entire HCV polyprotein do not exhibit hepatic inflammation and yet have an increased incidence of hepatocellular carcinoma (10). These data suggest that HCV proteins may have a direct oncogenic effect. Consistent with this, several structural and nonstructural proteins encoded by HCV (core, NS3, NS5A, and NS5B) have been shown to regulate host cell cycle regulators and tumor suppressor proteins, including p53 and the retinoblastoma protein (Rb) (7,8,14,17; for a recent review, see reference 16).Rb has many important functions in cell cycle control, including the repression of transcription factors needed for the transition from G 1 /G 0 to S phase. Rb is targeted by a number of DNA oncoviruses, including adenovirus (27), simian virus 40 (3), and human papillomavirus (5). These small DNA viruses exploit host cell machinery to facilitate genome replication, and they encode oncoproteins that can sequester Rb or downregulate its abundance. This results in the release of the Rb-imposed repression of ...